Related Experiment Videos
Antihypertensive mechanisms of lipid-lowering drugs: decoding the Rosetta stone's inscriptions'
1Clinica Medica, University of Milano-Bicocca, Ospedale San Gerardo, Monza, Milano, Italy.
Journal of Hypertension
|May 2, 2001
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Pathophysiology and Management of Type 2 Diabetes Mellitus Bone Fragility.
Journal of diabetes research·2020
Laser light triggered smart release of silibinin from a PEGylated-PLGA gold nanocomposite.
Journal of materials chemistry. B·2020
Hyperuricemia and Risk of Cardiovascular Outcomes: The Experience of the URRAH (Uric Acid Right for Heart Health) Project.
High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension·2020
Investigation on the thermal gelation of Chitosan/β-Glycerophosphate solutions.
Carbohydrate polymers·2019
Combined effects of nanoplastics and copper on the freshwater alga Raphidocelis subcapitata.
Aquatic toxicology (Amsterdam, Netherlands)·2019
The role of the immune system in hypertension.
Journal of hypertension·2026
Fibromuscular dysplasia and aortic involvement: a systematic review for a potential association.
Journal of hypertension·2026
Serum fatty acid profile and desaturase activity in hypertensive patients with and without metabolic syndrome.
Journal of hypertension·2026
Successful use of a Janus-kinase (JAK) inhibitor in chronic chikungunya arthritis refractory to conventional synthetic DMARDs: a case report.
Modern rheumatology case reports·2026
Simvastatin Mitigates Chemotherapy-Induced Depressive-Like Behaviors in Rats.
Archiv der Pharmazie·2026
The endophyte secondary metabolite phenazine-1-carboxylic acid promotes tanshinone biosynthesis in Salvia miltiorrhiza callus.
Journal of natural medicines·2026
The 'less side effect, more benefit' hypothesis: explaining the colchicine paradox.
Current medical research and opinion·2026
Psychedelics and disorders of consciousness: a new frontier in neurotherapeutics.
Molecular psychiatry·2026